Benjamin Boinem

Benjamin Boinem graduated from the University of Liège with a degree in Social Enterprise Management and Entrepreneurship. After completing his studies, he quickly became interested in the healthcare and hospital sectors, and helped two companies to develop: InoKura, the phase I clinical trials centre at Liège University Hospital, and Accessia Pharma, a company providing GMP infrastructure for the development of biotech and pharma companies in collaboration with local and national investment funds.

In 2022, Accessia Pharma was sold to Xpress Biologics, the company's biggest client, to enable it to develop its own activities. He then focused more intensively on developing clinical studies at the CHU de Liège and redeploying cutting-edge infrastructure in the Liège region to help local start-ups flourish.

Alongside these activities, he is a lecturer at the University of Liège and an independent director of a number of SMEs.